Theranostics for oncological therapy: results from worldwide research and the paths of development

Author:

Romodin L. A12

Affiliation:

1. State Scientific Center of the Russian Federation - A.I. Burnazyan Federal Medical Biophysical Center of the Federal Medical Biological Agency of Russia

2. Russian Biotechnological University

Abstract

Theranostics is a field of medicine with the aim to establish tools for a specific targeted therapy based on early diagnosis of diseases. This effect is primarily due to targeted delivery of the therapeutic agent to the target cells. The development of a clinically effective theranostic drug will be the greatest medical breakthrough. This paper presents an analytical mini-review of some modern approaches to find a solution to the core of the problems of theranostics for oncological therapy and discusses recent studies on the use of radiopharmaceuticals, that can be diagnostic and therapeutic, and systems for visualization of radiopharmaceuticals by means of magnetic resonance imaging for therapy of cancerous tumors. Information is given on application of various systems using fluorescent agents such as anti-Stokes fluorophores, the signal from which is well observed, compared to other fluorescent substances, on a background of the reflected irradiance from tissues surrounding cancer cells. This paper also presents details on the comparative use of classical chemotherapeutic agents and promising drugs developed on the basis of natural substances, for example, sulforaphane and cytochrome c, that have lower toxicity.

Publisher

The Russian Academy of Sciences

Reference30 articles.

1. А. Л. Долбов, А. А. Станжевский, Д. Н. Майстренко и др., Онкологич. журн.: лучевая диагностика, лучевая терапия, № 4 (4), 20 (2021).

2. А. А. Медведева, В. И. Чернов, Е. А. Усынин и др., Сибирский онкологич. журн., 20 (3), 115 (2021).

3. M. S. Rafael, S. Cohen-Gogo, M. S. Irwin, et al., PET clinics, 16 (3), 419 (2021).

4. О. А. Кучур, Д. О. Кузьмина, М. С. Духинова и А. А. Штиль, ActaNaturae, 13 (3), 65 (2021).

5. X. Q. Wang, W. Wang, M. Peng, and X. Z. Zhang, Biomaterials, № 266, 120474 (2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3